D4Ertd22e Activators
D4Ertd22e activators can be classified into two main categories based on their biochemical mechanisms. The first group, which includes Phorbol 12-myristate 13-acetate (PMA), Forskolin, 8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP), Epidermal Growth Factor (EGF), Tetradecanoylphorbol acetate (TPA), and Insulin, are indirect activators of D4Ertd22e. They activate various kinases, such as PKC, PKA, and Akt, which can phosphorylate and activate D4Ertd22e. For example, PMA and TPA activate PKC, which can phosphorylate D4Ertd22e, enhancing its activity. Similarly, Forskolin and 8-Br-cAMP increase the levels of cAMP, which activates PKA, another kinase that can phosphorylate and activate D4Ertd22e.
The second group of D4Ertd22e activators, including Okadaic acid, Calyculin A, LY294002, U0126, Rapamycin, and Wortmannin, act by inhibiting proteins that negatively regulate D4Ertd22e. Okadaic acid and Calyculin A inhibit protein phosphatases 1 and 2A, reducing the dephosphorylation of D4Ertd22e and allowing it to maintain its active state. LY294002 and Wortmannin inhibit PI3K, which enhances D4Ertd22e activation by increasing its phosphorylation level. U0126 inhibits MEK, enhancing D4Ertd22e activity by reducing the negative regulation of ERK, which can activate D4Ertd22e. Finally, Rapamycin inhibits mTOR, promoting the autophagy-related activation of D4Ertd22e.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC, in turn, can phosphorylate and activate D4Ertd22e as part of downstream signaling events. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylyl cyclase, which increases the levels of cyclic AMP (cAMP). cAMP can activate protein kinase A (PKA), which can phosphorylate and activate D4Ertd22e. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cell-permeable cAMP analog. It can activate PKA, which can phosphorylate and activate D4Ertd22e. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A. By inhibiting these phosphatases, it can prevent the dephosphorylation of D4Ertd22e, thus maintaining its active, phosphorylated state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is another potent inhibitor of protein phosphatases 1 and 2A. Like okadaic acid, it can maintain the phosphorylated, active state of D4Ertd22e by inhibiting its dephosphorylation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin can activate the PI3K-Akt pathway. Akt, also known as protein kinase B, can phosphorylate and activate D4Ertd22e. | ||||||